During the past decade, Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp" #1 collaborator was "Prologue Research International" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp" in a lesser frequency.

Most popular intervention types in "Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide and low-dose dexamethasone" (1 trials), "Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles" (1 trials), "Melphalan, Prednisone and Thalidomide" (1 trials), "dexamethasone" (1 trials) and "lenalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".